These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov 15; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]
10. Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes. McCarty TP, Lockhart SR, Moser SA, Whiddon J, Zurko J, Pham CD, Pappas PG. J Antimicrob Chemother; 2018 Jun 01; 73(6):1677-1680. PubMed ID: 29506044 [Abstract] [Full Text] [Related]
11. In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates. Bordallo-Cardona MÁ, Escribano P, de la Pedrosa EG, Marcos-Zambrano LJ, Cantón R, Bouza E, Guinea J. Antimicrob Agents Chemother; 2017 Feb 01; 61(2):. PubMed ID: 27872063 [Abstract] [Full Text] [Related]
18. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Zimbeck AJ, Iqbal N, Ahlquist AM, Farley MM, Harrison LH, Chiller T, Lockhart SR. Antimicrob Agents Chemother; 2010 Dec 01; 54(12):5042-7. PubMed ID: 20837754 [Abstract] [Full Text] [Related]
19. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates. Beyda ND, Liao G, Endres BT, Lewis RE, Garey KW. Antimicrob Agents Chemother; 2015 Sep 01; 59(9):5405-12. PubMed ID: 26100700 [Abstract] [Full Text] [Related]